Display options
Cite
Raheel M, Choga WT, Blackard JT. The distribution of hepatitis B virus surface antigen polymorphisms at positions associated with vaccine escape. J Med Virol. 2020;doi: 10.1002/jmv.25730.
Raheel, M., Choga, W. T., & Blackard, J. T. (2020). The distribution of hepatitis B virus surface antigen polymorphisms at positions associated with vaccine escape. Journal of medical virology, . https://doi.org/10.1002/jmv.25730
Raheel, Mahad, et al. "The distribution of hepatitis B virus surface antigen polymorphisms at positions associated with vaccine escape." Journal of medical virology vol. (2020). doi: https://doi.org/10.1002/jmv.25730
Raheel M, Choga WT, Blackard JT. The distribution of hepatitis B virus surface antigen polymorphisms at positions associated with vaccine escape. J Med Virol. 2020 Feb 27; doi: 10.1002/jmv.25730. Epub 2020 Feb 27. PMID: 32104912.
Copy Download .nbib Format: NLM
Share it on

J Med Virol. 2020 Feb 27; doi: 10.1002/jmv.25730. Epub 2020 Feb 27.

The distribution of hepatitis B virus surface antigen polymorphisms at positions associated with vaccine escape.

Journal of medical virology

Mahad Raheel, Wonderful T Choga, Jason T Blackard

Affiliations

  1. Division of Digestive Diseases, University of Cincinnati College of Medicine, Cincinnati, Ohio.
  2. Botswana-Harvard AIDS Partnership, Gaborone, Botswana.
  3. Division of Human Genetics, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

PMID: 32104912 DOI: 10.1002/jmv.25730

Abstract

Hepatitis B virus (HBV) infects over 250 million people worldwide. Vaccination is effective at preventing infection, although several mutations within the "a" determinant region of the HBV surface antigen (HBsAg) are associated with vaccine escape. We evaluated the frequency, genotype, and global distribution of polymorphisms at sites associated with vaccine escape in 4244 unique full-length HBV genomes. The "a" determinant within the Surface gene was inspected for polymorphisms at sites identified previously associated with vaccine escape. Nearly, 268 (6.3%) sequences from 36 countries contained a polymorphism at a site associated with vaccine escape including 22 genotype A, 99 genotype B, 93 genotype C, 32 genotype D, 14 genotype E, 3 genotype F, 2 genotype G, and 3 genotype I. In genotype A, the most common polymorphism occurred at M133. In genotype B, Q129 and M133 occurred 45 and 51 times, respectively, accounting for 94% of polymorphisms. Polymorphisms at G145 were most frequent in genotype C, while P120 was most common in genotype D. Among all genotypes, polymorphisms at M133 were the most common and accounted for 30.9% of polymorphisms. Polymorphisms at T116, P120, F134, K141, and P142 occurred in geographically diverse locations, whereas polymorphisms at Q129, M133, D144, and G145 were concentrated in East Asia. While the sample size is large, this approach relied on convenience sampling within each country, and many countries have no data available, thereby highlighting the need for additional routine surveillance of surface antigen mutations associated with vaccine escape.

© 2020 Wiley Periodicals, Inc.

Keywords: HBsAg; genotype; hepatitis B virus; mutation; polymorphism; vaccination; vaccine escape

References

  1. World Health Organization. Hepatitis B. 2019. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. Accessed September 9, 2019. - PubMed
  2. Carman WF, Karayiannis P, Waters J, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet. 1990;336(8711):325-329. - PubMed
  3. Zanetti AR, Tanzi E, Manzillo G, et al. Hepatitis B variant in Europe. Lancet. 1998;2(8620):1132-1133. - PubMed
  4. Lazarevic I. Clinical implications of hepatitis B virus mutations: recent advances. World J Gastroenterol. 2014;20(24):7653-7664. - PubMed
  5. Caligiuri P, Cerruti R, Icardi G, Bruzzone B. Overview of hepatitis B virus mutations and their implications in the management of infection. World J Gastroenterol. 2016;22(1):145-154. - PubMed
  6. Lazarevic I, Banko A, Miljanovic D, Cupic M. Immune-escape hepatitis B virus mutations associated with viral reactivation upon immunosuppression. Viruses. 2019;11(9):E778. - PubMed
  7. Hou J, Wang Z, Cheng J, et al. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology. 2001;34(5):1027-1034. - PubMed
  8. Schaefer S. Hepatitis B virus: significance of genotypes. J Viral Hepatitis. 2005;12(2):111-124. - PubMed
  9. Tanwar S, Dusheiko G. Is there any value to hepatitis B virus genotype analysis? Curr Gastroenterol Rep. 2012;14(1):37-46. - PubMed
  10. Okamoto H, Imai M, Kametani M, Nakamura T, Mayumi M. Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission. Jpn J Exp Med. 1987;57(4):231-236. - PubMed
  11. Pawlotsky J. The concept of hepatitis B virus mutant escape. J Clin Virol. 2005;34(suppl 1):S125-S129. - PubMed
  12. Romanò L, Paladini S, Galli C, Raimondo G, Pollicino T, Zanetti A. Hepatitis B vaccination. Human Vaccines Immunother. 2015;11(1):53-57. - PubMed
  13. Qin Y, Liao P. Hepatitis B virus vaccine breakthrough infection: surveillance of S gene mutants of HBV. Acta Virol. 2018;62:115-121. - PubMed
  14. Bell TG, Yousif M, Kramvis A. Bioinformatic curation and alignment of genotyped hepatitis B virus (HBV) sequence data from the GenBank public database. SpringerPlus. 2016;5(1):1896. - PubMed
  15. Lee PI, Chang LY, Lee CY, Huang LM, Chang M. Detection of hepatitis B surface gene mutation in carrier children with or without immunoprophylaxis at birth. J Infect Dis. 1997;176(2):427-430. - PubMed
  16. Hsu HY, Chang MH, Liaw SH, Ni YH, Chen H. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology. 1999;30(5):1312-1317. - PubMed
  17. Chen CY, Hsu HY, Liu CC, Chang MH, Ni Y. Stable seroepidemiology of hepatitis B after universal immunization in Taiwan: a 3-year study of national surveillance of primary school students. Vaccine. 2010;28(34):5605-5608. - PubMed
  18. Chong-Jin O, Wei Ning C, Shiuan K, Keow LG. Identification of hepatitis B surface antigen variants with alterations outside the "a" determinant in immunized Singapore infants. J Infect Dis. 1999;179(1):259-263. - PubMed
  19. Ghaziasadi A, Alavian SM, Norouzi M, Fazeli Z, Jazayeri S. Mutational analysis of HBs Ag-positive mothers and their infected children despite immunoprophylaxis. Iran J Allergy Asthma Immunol. 2013;12(4):352-360. - PubMed
  20. He C, Nomura F, Itoga S, Isobe K, Nakai T. Prevalence of vaccine-induced escape mutants of hepatitis B virus in the adult population in China: a prospective study in 176 restaurant employees. J Gastroenterol Hepatol. 2001;16(12):1373-1377. - PubMed
  21. Ngui SL, O'Connell S, Eglin RP, Heptonstall J, Teo C. Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales. J Infect Dis. 1997;176(5):1360-1365. - PubMed
  22. Hsu HY, Chang MH, Ni YH, Chen H. Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. Gut. 2004;53(10):1499-1503. - PubMed
  23. Yan B, Lv J, Feng Y, et al. Temporal trend of hepatitis B surface mutations in the post-immunization period: 9 years of surveillance (2005-2013) in eastern China. Scientific Reports 2017;7(1):6669. - PubMed
  24. Lada O, Benhamou Y, Poynard T, Thibault V. Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants. J Virol. 2006;80(6):2968-2975. - PubMed
  25. Ramachandran S, Groves JA, Xia G, et al. Recent and occult hepatitis B virus infections among blood donors in the United States. Transfusion. 2019;59(2):601-611. - PubMed
  26. Pande C, Sarin SK, Patra S, et al. Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial. J Viral Hepatitis. 2013;20(11):801-810. - PubMed
  27. Croagh CM, Desmond PV, Bell S. Genotypes and viral variants in chronic hepatitis B: a review of epidemiology and clinical relevance. World J Gastroenterol. 2015;7(3):289-303. - PubMed

Publication Types

Grant support